Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
26.13
+0.41 (1.59%)
Feb 21, 2025, 4:00 PM EST - Market closed
Smith & Nephew Employees
Smith & Nephew had 19,081 employees as of December 31, 2023. The number of employees decreased by 13 or -0.07% compared to the previous year.
Employees
19,081
Change (1Y)
-13
Growth (1Y)
-0.07%
Revenue / Employee
$295,687
Profits / Employee
$15,984
Market Cap
11.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19,081 | -13 | -0.07% |
Dec 31, 2022 | 19,094 | 118 | 0.62% |
Dec 31, 2021 | 18,976 | 395 | 2.13% |
Dec 31, 2020 | 18,581 | 551 | 3.06% |
Dec 31, 2019 | 18,030 | 1,349 | 8.09% |
Dec 31, 2018 | 16,681 | 348 | 2.13% |
Dec 31, 2017 | 16,333 | 749 | 4.81% |
Dec 31, 2016 | 15,584 | 898 | 6.11% |
Dec 31, 2015 | 14,686 | 1,218 | 9.04% |
Dec 31, 2014 | 13,468 | 2,432 | 22.04% |
Dec 31, 2013 | 11,036 | 559 | 5.34% |
Dec 31, 2012 | 10,477 | -266 | -2.48% |
Dec 31, 2011 | 10,743 | 571 | 5.61% |
Dec 31, 2010 | 10,172 | 408 | 4.18% |
Dec 31, 2009 | 9,764 | 7 | 0.07% |
Dec 31, 2008 | 9,757 | 567 | 6.17% |
Dec 31, 2007 | 9,190 | 360 | 4.08% |
Dec 31, 2006 | 8,830 | 212 | 2.46% |
Dec 31, 2005 | 8,618 | 752 | 9.56% |
Dec 31, 2004 | 7,866 | 415 | 5.57% |
Feb 16, 2003 | 7,451 | -55 | -0.73% |
Dec 31, 2002 | 7,506 | -420 | -5.30% |
Dec 31, 2001 | 7,926 | -2,509 | -24.04% |
Dec 31, 2000 | 10,435 | -778 | -6.94% |
Dec 31, 1999 | 11,213 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
SNN News
- 5 days ago - Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand - GlobeNewsWire
- 18 days ago - Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes - GlobeNewsWire
- 24 days ago - Smith & Nephew Getting No Credit For Self-Improvement Efforts - Seeking Alpha
- 5 weeks ago - Smith+Nephew's ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable' Evidence Bar™ ratings from ECRI for pressure injury prevention - GlobeNewsWire
- 5 weeks ago - Topical Scar Treatment Market to Grow from $1.71 Billion in 2024 to $5.91 Billion by 2035 - Dominated by Smith & Nephew, Molnlycke Health Care, Alliance Pharma, HRA Pharma, and Rejuvaskin - GlobeNewsWire
- 2 months ago - Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty - GlobeNewsWire
- 2 months ago - Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty - GlobeNewsWire
- 3 months ago - Big investors call for break-up of Smith & Nephew, FT reports - Reuters